Drug intelligence / Profile preview

Yixin Keli

Development stage: Unknown
Administration: Oral

Overview

Yixin Keli (颐心颗粒), also known as Qidong Yixin Keli (芪冬颐心颗粒), is a Traditional Chinese Medicine (TCM) formulated as granules. It is composed of multiple herbal ingredients including Astragalus membranaceus, Ophiopogon japonicus, Panax ginseng, Poria cocos, Rehmannia glutinosa, Plastrum Testudinis, Fluoritum, Cinnamomum cassia twig, Epimedium brevicornu, Lonicera japonica, Salvia miltiorrhiza, Curcuma longa, and Citrus aurantium. This prescription drug is indicated for conditions characterized by deficiency of both Qi and Yin (气阴两虚), such as heart palpitations, chest tightness, chest pain, shortness of breath, fatigue, insomnia, sweating, and vexation. It is specifically used in the treatment of viral myocarditis and coronary heart disease angina pectoris presenting with these symptoms.

Other names: 颐心颗粒Qidong Yixin Keli芪冬颐心颗粒

Targets

NCX1 (Sodium/calcium exchanger 1)

Beyond the preview

Go deeper on Yixin Keli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yixin Keli.

Explore the full profile